Trends in global prescribing of antidiabetic medicines in primary care: A systematic review of literature between 2000–2018

Sara Ramzan; Peter Timmins; Syed Shahzad Hasan; Zaheer-Ud-Din Babar

doi:10.1016/j.pcd.2019.05.009

Trends in global prescribing of antidiabetic medicines in primary care: A systematic review of literature between 2000–2018

Sara Ramzan, Peter Timmins, Syed Shahzad Hasan, Zaheer-Ud-Din Babar

Research output: Contribution to journal › Review article › peer-review

19 Citations (Scopus)

Abstract

The aim of this review was to examine changes in the use of diabetes medicines prescribed to treat type 2 diabetes in the primary care setting. Five electronic databases were searched using strict inclusion/exclusion criteria. The quality of eligible studies was appraised using the Newcastle–Ottawa Scale. Findings show the trend has been away from using sulfonylurea and towards the use of metformin. The introduction of newer drugs has not shifted treatment outcomes and glycaemic control. It was not possible to determine how clinicians make choices about the medicines they prescribe for T2DM, or what influences those choices.

Original language	English
Pages (from-to)	409-421
Number of pages	13
Journal	Primary Care Diabetes
Volume	13
Issue number	5
Early online date	15 Jun 2019
DOIs	https://doi.org/10.1016/j.pcd.2019.05.009
Publication status	Published - 1 Oct 2019

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1016/j.pcd.2019.05.009Licence: Unspecified

Prescription_pattern_manuscript_24_03_2019_cleanAccepted author manuscript, 713 KBLicence: CC BY-NC-ND

Cite this

@article{eebabdd3990647328718f5db1d7fa192,

title = "Trends in global prescribing of antidiabetic medicines in primary care: A systematic review of literature between 2000–2018",

abstract = "The aim of this review was to examine changes in the use of diabetes medicines prescribed to treat type 2 diabetes in the primary care setting. Five electronic databases were searched using strict inclusion/exclusion criteria. The quality of eligible studies was appraised using the Newcastle–Ottawa Scale. Findings show the trend has been away from using sulfonylurea and towards the use of metformin. The introduction of newer drugs has not shifted treatment outcomes and glycaemic control. It was not possible to determine how clinicians make choices about the medicines they prescribe for T2DM, or what influences those choices.",

author = "Sara Ramzan and Peter Timmins and Hasan, \{Syed Shahzad\} and Zaheer-Ud-Din Babar",

year = "2019",

month = oct,

day = "1",

doi = "10.1016/j.pcd.2019.05.009",

language = "English",

volume = "13",

pages = "409--421",

journal = "Primary Care Diabetes",

issn = "1751-9918",

publisher = "Elsevier Limited",

number = "5",

}

TY - JOUR

T1 - Trends in global prescribing of antidiabetic medicines in primary care

T2 - A systematic review of literature between 2000–2018

AU - Ramzan, Sara

AU - Timmins, Peter

AU - Hasan, Syed Shahzad

AU - Babar, Zaheer-Ud-Din

PY - 2019/10/1

Y1 - 2019/10/1

N2 - The aim of this review was to examine changes in the use of diabetes medicines prescribed to treat type 2 diabetes in the primary care setting. Five electronic databases were searched using strict inclusion/exclusion criteria. The quality of eligible studies was appraised using the Newcastle–Ottawa Scale. Findings show the trend has been away from using sulfonylurea and towards the use of metformin. The introduction of newer drugs has not shifted treatment outcomes and glycaemic control. It was not possible to determine how clinicians make choices about the medicines they prescribe for T2DM, or what influences those choices.

AB - The aim of this review was to examine changes in the use of diabetes medicines prescribed to treat type 2 diabetes in the primary care setting. Five electronic databases were searched using strict inclusion/exclusion criteria. The quality of eligible studies was appraised using the Newcastle–Ottawa Scale. Findings show the trend has been away from using sulfonylurea and towards the use of metformin. The introduction of newer drugs has not shifted treatment outcomes and glycaemic control. It was not possible to determine how clinicians make choices about the medicines they prescribe for T2DM, or what influences those choices.

UR - https://www.scopus.com/pages/publications/85067098423

U2 - 10.1016/j.pcd.2019.05.009

DO - 10.1016/j.pcd.2019.05.009

M3 - Review article

SN - 1751-9918

VL - 13

SP - 409

EP - 421

JO - Primary Care Diabetes

JF - Primary Care Diabetes

IS - 5

ER -

Trends in global prescribing of antidiabetic medicines in primary care: A systematic review of literature between 2000–2018

Abstract

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this